U.S. Seeks Balance On Drug Access In Trans Pacific Partnership IP Talks
This article was originally published in PharmAsia News
Executive Summary
The United States remains hopeful that a sharp debate on access and stricter intellectual property rules in the TPP talks can be concluded by the end of the year after talks in Indonesia failed to break an impasse.
You may also be interested in...
Free Trade Talks In Asia And Europe Impeded By Government Shutdown
As the shutdown continues, President Obama’s absence at negotiations on the Trans-Pacific Partnership could delay finalization of the free trade agreement. In addition, talks toward an EU-U.S. trade pact were canceled. Both agreements are expected to address device-specific trade issues.
Mixed Impact From Indonesian Foreign Ownership Changes?
A new economic stimulus package from the Indonesian government that includes allowing up to 100% foreign ownership in the pharmaceutical and health sectors has been welcomed by the multinational industry.
Indonesian Insurance Scheme ‘Not Sharia-Compliant’, Muslim Body Says
An edict by a top Muslim council in Indonesia that the country’s national health insurance does not follow Islamic sharia law principles has sparked debate in the world’s most populous Muslim-majority country.